一例罗赛-多夫曼病例通过皮质疗法成功治疗
Alioune Badara Diallo1, Moustapha Ndiaye2, Moussa Seck1
1Hematology Department, Cheikh Anta Diop University, Dakar, Senegal.
Case reports in hematology
|May 1, 2024
概括
罗莎-多尔夫曼病 (RDD) 是一种罕见的囊细胞性疾病. 本案例报告详细介绍了由于RDD导致的快速进展性宫淋巴腺病症的儿童的成功皮质类固醇治疗.
科学领域:
- 囊细胞性疾病 囊细胞性疾病
- 儿科瘤学 儿科瘤学
- 免疫病理学 免疫病理学
背景情况:
- 罗莎-多夫曼病 (RDD) 是一种罕见的良性囊细胞增殖,具有节点和节外表现.
- 由于其罕见 (报告的病例少于1000例),医生意识有限,治疗策略有条目.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
116
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
116
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
160
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
160


